
Please try another search
Divi's Laboratories Limited is an India-based company, which is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. The Company’s subsidiaries include Divi’s Laboratories USA, Inc., (Divi’s USA) and Divi’s Laboratories Europe AG (Divi’s Europe).
Name | Age | Since | Title |
---|---|---|---|
Kiran Satchandra Divi | 46 | 2001 | CEO & Whole-Time Director |
Gangavarapu Suresh Kumar | 71 | 2001 | Non-Executive Independent Director |
Sunaina Singh | 66 | 2019 | Non-Executive Independent Director |
Kosaraju Veerayya Chowdary | 68 | 2020 | Non-Executive Independent Director |
Ranga Rao Ravipati | 71 | 2012 | Non-Executive Independent Director |
Rameshbabu Venkata Nimmagadda | - | 2017 | Independent Non-Executive Chairman |
Kantheti Venkata Krishna Seshavataram | 81 | 2014 | Non-Executive Independent Director |
Venkata Ramana Nimmagadda | 64 | - | Executive Director |
Madhusudana Rao Divi | 78 | - | Director of Projects & Whole-Time Director |
Murali Krishna Prasad Divi | 71 | 1990 | MD & Executive Director |
Nilima Prasad Divi | 40 | 2021 | Whole-time Director & Director of Commercial |
Seru Ganapaty | 69 | 2017 | Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review